Press Releases
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
Dec 17, 2024
Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers
Dec 04, 2024
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
Nov 19, 2024
Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
Nov 01, 2024
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million
Oct 30, 2024
Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
Oct 30, 2024
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
Sep 19, 2024
Tiziana Life Sciences Appoints New Chief Executive Officer
Aug 19, 2024
Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
Aug 14, 2024
Tiziana Life Sciences Granted FDA Fast Track Designation
Jul 24, 2024
Displaying 1 - 10 of 485